Oppenheimer & Co. Inc. grew its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 71.2% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 10,340 shares of the company's stock after purchasing an additional 4,302 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.06% of Addus HomeCare worth $1,023,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. New York State Common Retirement Fund boosted its holdings in Addus HomeCare by 6.0% in the fourth quarter. New York State Common Retirement Fund now owns 14,098 shares of the company's stock valued at $1,767,000 after acquiring an additional 800 shares during the last quarter. Handelsbanken Fonder AB lifted its stake in shares of Addus HomeCare by 17.2% in the 4th quarter. Handelsbanken Fonder AB now owns 4,083 shares of the company's stock valued at $512,000 after purchasing an additional 600 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Addus HomeCare in the 4th quarter valued at about $258,000. Illinois Municipal Retirement Fund grew its holdings in shares of Addus HomeCare by 2.4% during the 4th quarter. Illinois Municipal Retirement Fund now owns 9,657 shares of the company's stock worth $1,211,000 after purchasing an additional 223 shares during the period. Finally, Proficio Capital Partners LLC acquired a new stake in Addus HomeCare during the 4th quarter worth approximately $1,933,000. Hedge funds and other institutional investors own 95.35% of the company's stock.
Addus HomeCare Stock Up 1.4%
ADUS traded up $1.49 during trading hours on Thursday, reaching $111.86. 91,160 shares of the stock traded hands, compared to its average volume of 165,861. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a market cap of $2.06 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 1.60 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74. The firm's fifty day simple moving average is $111.13 and its two-hundred day simple moving average is $111.52.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period last year, the firm earned $1.21 earnings per share. The company's revenue was up 20.3% on a year-over-year basis. As a group, analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
ADUS has been the topic of several research reports. Macquarie restated an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Stephens reissued an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday. Finally, JMP Securities reiterated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Friday, June 20th. Seven analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of "Buy" and an average price target of $142.57.
View Our Latest Analysis on Addus HomeCare
Insider Transactions at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president directly owned 7,796 shares of the company's stock, valued at $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 4.60% of the stock is owned by corporate insiders.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.